Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Sao Paulo Med J ; 142(4): e2022641, 2024.
Article in English | MEDLINE | ID: mdl-38655989

ABSTRACT

BACKGROUND: Adolescence is characterized by complex and dynamic changes, often involving experimentation, including the use of psychotropic substances. Although it is well-established that recreational psychotropic drugs are associated with suicide ideation in adults, evidence of this association in adolescents remains limited. OBJECTIVE: To investigate the relationship between suicide ideation and psychotropic recreational drug use among adolescents. DESIGN AND SETTING: Systematic review with meta-analysis developed at Universidade Federal de Uberlândia (UFU) and Universidade Estadual de Campinas (UNICAMP), Brazil. METHODS: A search across eight electronic databases for observational studies, without language or publication year restrictions, was conducted. The Joanna Briggs Institute tool was used to assess the risk of bias. Random-effects meta-analyses and odds ratios were used to measure the effects. RESULTS: The search yielded 19,732 studies, of which 78 were included in the qualitative synthesis and 32 in the meta-analysis. The findings indicated that suicidal ideation was 1.96 times more likely (95% confidence interval, CI = 1.47; 2.61) for adolescents who used some drug recurrently and 3.32 times more likely (95%CI = 1.86; 5.93) among those who abused drugs. Additionally, adolescents who used cannabis were 1.57 times more likely (95%CI = 1.34; 1.84) to experience suicide ideation compared with non-users, while cocaine users had 2.57 times higher odds (95%CI = 1.47; 4.50). CONCLUSIONS: Psychotropic recreational drug use is associated with suicidal ideation among adolescents regardless of current or previous use, abuse, or type of substance used. SYSTEMATIC REVIEW REGISTRATION: Registered in the PROSPERO database under the identification number CRD42021232360. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021232360.


Subject(s)
Psychotropic Drugs , Recreational Drug Use , Suicidal Ideation , Humans , Adolescent , Recreational Drug Use/statistics & numerical data , Recreational Drug Use/psychology , Substance-Related Disorders/psychology , Substance-Related Disorders/epidemiology , Risk Factors , Brazil/epidemiology , Illicit Drugs , Male , Female
2.
J Neurol ; 271(6): 3340-3346, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38478030

ABSTRACT

BACKGROUND: Recreational nitrous oxide (N2O) use has become more widespread worldwide, leading to an increase in myelopathies and peripheral neuropathies. The aim of this study was to describe clinical and socioeconomical characteristics of severe N2O-induced (NI) neurological disorders (NI-NDs), to determine its incidence in the Greater Paris area and to compare it with that of similar inflammatory neurological disorders. METHODS: We performed a retrospective multicentric cohort study of all adult patients with severe NI-NDs in the neurology and general internal medicine departments of the Greater Paris area from 2018 to 2021. The incidence was compared with that of non-NI-myelitis and Guillain-Barré syndrome (GBS) using a sample of 91,000 hospitalized patients sourced from health insurance data. RESULTS: Among 181 patients, 25% had myelopathy, 37% had peripheral neuropathy and 38% had mixed disease. Most were aged between 20 and 25 years, lived in socially disadvantaged urban areas, and exhibited high rates of unemployment (37%). The incidence of NI-NDs increased during 2020 and reached a peak mid-2021. The 2021 incidence in 20-25-year-olds was 6.15 [4.72; 8.24] per 100,000 persons for NI-myelopathy and 7.48 [5.59; 9.37] for NI-peripheral neuropathy. This was significantly higher than for non-NI-myelitis (0.35 [0.02; 2.00]) and GBS (2.47 [0.64; 4.30]). The incidence of NI-NDs was two to three times higher in the most socially disadvantaged areas. CONCLUSION: The recent increase in recreational N2O use has led to a rise in the incidence of severe NI-NDs, particularly in young adults with low socioeconomic status for whom NI-NDs strongly outweigh similar neurological disorders.


Subject(s)
Nitrous Oxide , Substance-Related Disorders , Humans , Nitrous Oxide/adverse effects , Male , Female , Adult , Retrospective Studies , Paris/epidemiology , Young Adult , Middle Aged , Incidence , Substance-Related Disorders/epidemiology , Nervous System Diseases/epidemiology , Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/epidemiology , Peripheral Nervous System Diseases/chemically induced , Spinal Cord Diseases/epidemiology , Spinal Cord Diseases/chemically induced , Aged , Adolescent , Recreational Drug Use/statistics & numerical data
3.
Drug Alcohol Rev ; 42(6): 1547-1552, 2023 09.
Article in English | MEDLINE | ID: mdl-37102194

ABSTRACT

INTRODUCTION: It is largely unknown whether adverse effects experienced from recreational drug use affect willingness to use again. This study determined whether adverse effects from select party drugs affect reported willingness to use again in the next month among a high-risk population-people who attend electronic dance music parties at nightclubs or dance festivals. METHODS: Adults (age ≥ 18) entering nightclubs/festivals were surveyed in New York City in 2018-2022 (n = 2981). Participants were asked about past-month use of common party drugs (cocaine, ecstasy, lysergic acid diethylamide [LSD] and ketamine), whether they had experienced a harmful or very unpleasant effect after use in the past 30 days, and whether they intend to use again in the next 30 days if offered by a friend. The relationship between having experienced an adverse outcome and willingness to use again was examined in a bivariable and multivariable manner. RESULTS: Experiencing an adverse effect after past-month cocaine (adjusted prevalence ratio [aPR] = 0.58, 95% confidence interval [CI] 0.35-0.95) or ecstasy use (aPR = 0.45, 95% CI 0.25-0.80) was associated with lower risk for willingness to use again. Adverse effects related to LSD use were related to lower risk of being willing to use again in the bivariable model, but in multivariable models, risk was not attenuated for willingness to use LSD or ketamine again. DISCUSSION AND CONCLUSIONS: Personally experienced adverse effects can deter willingness to use certain party drugs again in this high-risk population. Interventions targeting cessation of recreational party drug use can likely benefit from focusing on deleterious effects of use that have been experienced.


Subject(s)
Dancing , Drug Users , Holidays , Illicit Drugs , Life Change Events , Music , Recreational Drug Use , Recreational Drug Use/psychology , Recreational Drug Use/statistics & numerical data , Illicit Drugs/adverse effects , Drug Users/psychology , Humans , New York City , Lysergic Acid Diethylamide/administration & dosage , Lysergic Acid Diethylamide/adverse effects , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , Cocaine/administration & dosage , Cocaine/adverse effects , Ketamine/administration & dosage , Ketamine/adverse effects , Time Factors , Male , Female , Adult
4.
LGBT Health ; 10(3): 191-201, 2023 04.
Article in English | MEDLINE | ID: mdl-36367714

ABSTRACT

Purpose: Sexual minority women and gender diverse individuals assigned female at birth (SMW+) consistently report more alcohol and other drug (AOD) use severity than heterosexual women, with greater disparities reported among bisexual plus (bi+) SMW (including bisexual, pansexual, queer, and those with attractions to more than one gender regardless of identity). Furthermore, emerging evidence suggests that SMW with masculine gender expression (e.g., SMW with masculine gender appearance) disproportionately experience problematic AOD use compared to those with feminine gender expression. The minority stress model, which has predominantly been investigated in relation to internalized homonegativity and sexuality-based discrimination, may also account for these AOD use disparities. This study examined gender expression, related discrimination, and AOD use severity among SMW+. Methods: In a 2020 sample of SMW+ (n = 236), we investigated AOD use severity in relation to gender expression (appearance, emotional expression, and gender roles) and gender expression-based discrimination after controlling for internalized homonegativity and sexuality-based discrimination through an online survey. Results: Masculine gender roles were associated with AOD use severity, whereas masculine appearance and emotional expression were not. In multivariable models, gender identity was inconsistently associated with alcohol use severity, sexuality-based discrimination was consistently associated with alcohol use severity and inconsistently associated with other drug use severity, and gender expression-based discrimination was associated with neither. Conclusion: This study emphasizes the importance of examining intersecting aspects of minority identity among SMW+, including facets of gender expression, in relation to AOD use severity.


Subject(s)
Alcohol Drinking , Gender Identity , Recreational Drug Use , Sexual and Gender Minorities , Humans , Female , Adult , Adolescent , Young Adult , Middle Aged , Gender Role , Alcohol Drinking/epidemiology , Alcohol Drinking/psychology , Recreational Drug Use/psychology , Recreational Drug Use/statistics & numerical data , Sexual and Gender Minorities/psychology , Sexual and Gender Minorities/statistics & numerical data , Sexual Behavior , Prejudice , Linear Models
5.
Am J Emerg Med ; 52: 8-12, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34856440

ABSTRACT

INTRODUCTION: The incidence of alcohol and recreational drug use is increasing. The impact on penetrating trauma is unknown. This study was undertaken to identify the incidence of alcohol and recreational drug use prior to penetrating trauma, and to identify ISS and outcomes among patients with penetrating trauma. METHODS: In this retrospective study, eligible subjects included trauma patients age 18 and older, with major trauma (admitted or evaluated by the Trauma Team) from 2017 to 2021. A chart review was conducted to identify data including mechanism of injury, ISS, alcohol level, toxicologic testing, length of stay, and final disposition. RESULTS: Among 1270 adult subjects with penetrating trauma during 2017 through 2020, the majority were male (N = 1071; 84%), and African American (N = 679; 54.3%) or White (N = 537; 42.9%). Mechanisms of injury included gunshot wound (GSW) (N = 973; 76.6%) or stab wound (N = 297; 23.4%). Injury severity score (ISS) ranged from 1 to 75. Among 426 subjects (33.5%) tested for recreational drugs, 395 (93%) were positive for at least one substance. The most common recreational drugs identified included marijuana (N = 280; 65.7%), benzodiazepine ((N = 131;30.8%), alcohol ((N = 248; 25.3%), opiate ((N = 116; 27.2%), cocaine (N = 87; 20.4%), and amphetamine ((N = 84; 19.7%). Subjects with an ISS of 9 to 15 had higher odds of testing positive for opiates compared to subjects with an ISS of 1 to 3 (OR 2.3). Most patients were ultimately discharged home ((N = 912;71.8%) and a minority expired (N = 142; 11.2%). CONCLUSIONS: Positive screens for alcohol and recreational drugs were common among penetrating trauma patients in this setting. The most common identified recreational drugs included marijuana, benzodiazepine, opiates, alcohol, cocaine, and amphetamine.


Subject(s)
Alcohol Drinking/epidemiology , Recreational Drug Use/statistics & numerical data , Wounds, Gunshot/epidemiology , Wounds, Stab/epidemiology , Adult , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Male , Retrospective Studies , Severity of Illness Index
6.
PLoS One ; 16(11): e0260322, 2021.
Article in English | MEDLINE | ID: mdl-34797874

ABSTRACT

BACKGROUND: The measures implemented by governments worldwide to control and prevent the spread of the COVID-19 have impacted the populations and directly influenced individuals' quality of life and consumption habits. OBJECTIVE: This work investigates the Portuguese population's changes in alcohol, stimulants drinks, illegal substances, and pharmaceutical consumptions habits during the COVID-19 pandemic. METHODS: An online questionnaire comprising seven groups of questions-with one group referring to alcohol, stimulant drinks, illegal substances, and pharmaceuticals consumption habits-was made available to the general adult population of mainland Portugal from the 26th January through the 31st of March 2021. After applying the inclusion criteria, 1666 questionnaires were selected and analysed using descriptive and inferential statistics. RESULTS: Our results show that 48.9% of the participants have alcohol drinking habits and increased their alcohol consumption by 16% after the beginning of the COVID-19 pandemic lockdown. Furthermore, 8.7% of the respondents felt the need to increase their consumption of stimulant drinks, especially coffee, the most consumed stimulant drink (77.9%). We also observed that of the 3.1% of respondents who are usual consumers of illegal substances, 26.9% increased their consumption of these substances during the COVID-19 pandemic. Concerning pharmaceuticals, 23.2% of the respondents expressed their need to take a therapeutic drug after the start of the COVID-19 pandemic. The profile of common consumers of alcohol, stimulant drinks, illegal substances, and pharmaceuticals in the COVID-19 pandemic context is contrasting and varies according to gender, age, and employment status. CONCLUSIONS: The COVID-19 pandemic led to an increase in the consumption of alcohol, stimulant drinks, illegal substances, and pharmaceuticals prescribed to treat anxiety, depression, and sleep changes in the Portuguese population. These new consumption patterns have probably aggravated domestic violence, mental diseases, and impairment of family quality of life in the Portuguese population.


Subject(s)
Alcohol Drinking/epidemiology , COVID-19/epidemiology , Recreational Drug Use/statistics & numerical data , Substance-Related Disorders/epidemiology , Adult , Aged , Aged, 80 and over , COVID-19/psychology , Central Nervous System Stimulants/administration & dosage , Female , Humans , Illicit Drugs , Male , Middle Aged , Portugal , Self Administration , Socioeconomic Factors
7.
Urology ; 156: 163-168, 2021 10.
Article in English | MEDLINE | ID: mdl-34273403

ABSTRACT

OBJECTIVE: To better understand patient experience, risk factors, culture, and ED outcomes surrounding recreational ICI use that led to ischemic priapism. METHODS: After IRB approval, men presenting for ischemic priapism secondary to recreational ICI use from January 2010 to December 2018 were contacted by mail and then via telephone. Standardized questions were asked of all study participants on the topics of erectile function (IIEF-5), sexual practices, and at-risk behavior at the time of priapism. Qualitative data analysis was performed using grounded theory methodology. RESULTS: 14 men age 24-59 were successfully recruited. All men described themselves as men having sex with men (MSM) and one (7.1%) as having both male and female sexual partners. Average follow up IIEF-5 among participants was 13 (SD 4.0). Eleven men (78.6 %) described illicit drug use at the time of priapism. Qualitative data analysis yielded several preliminary themes: concomitant drug use, naivety, peer pressure, and delay in seeking treatment. Men frequently reported illicit drug use in group sex scenarios and ICI use under pressure to perform sexually or to counteract effects of illicit substances. CONCLUSIONS: Recreational ICI in this cohort was part of a lifestyle of risky behavior. Methamphetamine use and group sex encounters strongly motivate recreational ICI use. Substance abuse centers may offer an entry point into this population for counseling and primary prevention.


Subject(s)
Erectile Dysfunction , Ischemia , Penile Erection/drug effects , Phosphodiesterase 5 Inhibitors , Priapism , Recreational Drug Use , Adult , Erectile Dysfunction/drug therapy , Erectile Dysfunction/prevention & control , Erectile Dysfunction/psychology , Follow-Up Studies , Genitourinary Agents/administration & dosage , Genitourinary Agents/adverse effects , Homosexuality, Male/psychology , Homosexuality, Male/statistics & numerical data , Humans , Illicit Drugs/pharmacology , Ischemia/diagnosis , Ischemia/etiology , Male , Penile Erection/physiology , Penile Erection/psychology , Penis/blood supply , Penis/drug effects , Phosphodiesterase 5 Inhibitors/administration & dosage , Phosphodiesterase 5 Inhibitors/adverse effects , Priapism/diagnosis , Priapism/etiology , Recreational Drug Use/psychology , Recreational Drug Use/statistics & numerical data , Risk Factors , Risk-Taking , Sexual Behavior/drug effects , Time
8.
BMC Pregnancy Childbirth ; 21(1): 530, 2021 Jul 28.
Article in English | MEDLINE | ID: mdl-34315424

ABSTRACT

BACKGROUND: A woman's health at the time of conception lays the foundation for a healthy pregnancy and the lifelong health of her child. We investigated the health behaviours of UK women planning pregnancy. METHODS: We analysed survey data from the 'Planning for Pregnancy' online tool (Tommy's, UK). We described all women planning pregnancy and compared the frequency of non-adherence to preconception recommendations in women who had already stopped contraception (active planners) and those who had not (non-active planners). RESULTS: One hundred thirty-one thousand one hundred eighty-two women from across the UK were included, of whom 64.8% were actively planning pregnancy. Of the whole cohort, twenty percent were smokers and less than one third took folic acid supplements (31.5%). Forty two percent engaged in less than the recommended 150 min of weekly physical activity and only 53.3% consumed five portions of fruit or vegetables 4 days a week. Smokers were 1.87 times more likely to be active planners than non-smokers (95% CI 1.79-1.94), and women who took folic acid were 7 times more likely to be active planners (95% CI 6.97-7.59) compared to women who did not. Smoking, drug use and lack of folic acid supplementation were common in younger women and those who were underweight. CONCLUSIONS: This unique survey of UK women has identified poor adherence to preconception recommendations in those planning pregnancies and supports the need for a greater public health focus on preconception health. This study provides a contemporary basis from which to inform preconception health advice and a benchmark to measure changes over time.


Subject(s)
Health Behavior , Health Knowledge, Attitudes, Practice , Preconception Care , Adult , Alcohol Drinking/epidemiology , Caffeine/administration & dosage , Cohort Studies , Dietary Supplements , Female , Folic Acid/administration & dosage , Fruit , Humans , Pregnancy , Recreational Drug Use/statistics & numerical data , Smoking/epidemiology , United Kingdom/epidemiology , Vegetables , Young Adult
9.
J Psychopharmacol ; 35(11): 1315-1323, 2021 11.
Article in English | MEDLINE | ID: mdl-34182812

ABSTRACT

BACKGROUND: 'Legal highs' began appearing in the UK in the mid-2000s. Whilst many of these substances were controlled under the 1971 Misuse of Drugs Act, novel compounds and new variants of controlled compounds were continuously being introduced to the recreational drug market. The Psychoactive Substances Act (PSA) was therefore implemented in 2016 as a blanket ban on all novel psychoactive substances (NPS). AIM: To evaluate the impact of the PSA on deaths following NPS use in England, Wales and Northern Ireland. METHODS: Cases reported to the National Programme on Substance Abuse Deaths where death had occurred 3 years pre- or post-implementation of the PSA were extracted. Cases with NPS detected at post-mortem were analysed and compared against cases non-NPS cases. RESULTS: 293 deaths with NPS detected were identified; 91 occurring before the PSA and 202 afterwards, indicating an 222.0% post-PSA increase. Contrastingly, non-NPS drug-related death case reporting increased by only 8.0%. Synthetic cannabinoid, anxiolytic/sedative and stimulant NPS were detected in the largest proportions of deaths pre-PSA; post-PSA stimulant NPS detections reduced whilst synthetic cannabinoid and anxiolytic/sedative detections increased.Post-PSA, average decedent age increased significantly (mean age pre-PSA 34.4 ± 10.8 vs post-PSA 38.3 ± 9.4), and they were significantly more likely to have been living in deprived areas (pre-PSA 50.0% vs post-PSA 65.9%). CONCLUSIONS: Reporting of deaths following NPS use has risen despite introduction of the PSA. Whilst deaths amongst younger individuals and those living in more affluent areas has reduced, additional approaches to prohibition are needed to curb their persistence in deprived demographics.


Subject(s)
Legislation, Drug , Psychotropic Drugs/poisoning , Recreational Drug Use/statistics & numerical data , Substance-Related Disorders/mortality , Adolescent , Adult , England/epidemiology , Female , Humans , Male , Middle Aged , Northern Ireland/epidemiology , Wales/epidemiology , Young Adult
10.
J Psychopharmacol ; 35(11): 1324-1348, 2021 11.
Article in English | MEDLINE | ID: mdl-34092131

ABSTRACT

BACKGROUND: Ketamine is a phencyclidine derivative with dissociative anaesthetic properties. Increasing numbers of individuals in England take ketamine recreationally. Information on deaths arising from such use in England is presented. METHODS: Cases were extracted on 31 January 2020 from the National Programme on Substance Abuse Deaths database, based on text searches of the cause of death, coroner's verdict and positive toxicology results for the terms 'ketamine' or 'norketamine'. FINDINGS: During 1997-2005, there were <5 deaths p.a. in which ketamine was implicated. Numbers increased until 2009 (21), plateauing until 2016; thereafter, deaths have risen to about 30 p.a. Decedents' characteristics (N = 283): male 84.1%, mean age 31.2 (SD 10.0) years, employed 56.5%, drug use history 79.6% and living with others 60.3%. Ketamine was detected with other substances in most cases. Main (74.6%) underlying cause of death was accidental poisoning. Ketamine may have impaired judgement in other cases. CONCLUSIONS: Although controlled, recreational ketamine use and related fatalities continue to increase. Consumers need to be more aware of the potentially fatal risks they face.


Subject(s)
Anesthetics, Dissociative/poisoning , Illicit Drugs/poisoning , Ketamine/poisoning , Recreational Drug Use/statistics & numerical data , Substance-Related Disorders/mortality , Adolescent , Adult , England/epidemiology , Female , Humans , Male , Middle Aged , Prevalence , Young Adult
11.
Pharmacol Biochem Behav ; 204: 173169, 2021 05.
Article in English | MEDLINE | ID: mdl-33684453

ABSTRACT

BACKGROUND: This paper examines the epidemiology of extra-medical use of prescription medications for sleep among a nationally representative sample of U.S. adults. METHODS: We analyzed data from the 2015-2018 National Surveys on Drug Use and Health. The sample includes 3410 U.S. adults who reported extra-medical use of prescription medications for sleep. Multinomial logistic regression models identified correlates of type of drug used [i.e., sedatives and/or tranquilizers-only (ST-only), prescription pain relievers-only (PPR-only), or sedatives, tranquilizers, and prescription pain relievers (ST + PPR)], and logistic regression models identified correlates of reasons for extra-medical use (i.e., sleep-only vs. sleep and recreational). RESULTS: About 60% (95%CI = 58.9, 63.5) of the sample reported extra-medical use of ST-only, followed by PPR-only (29.9%, 95%CI = 27.5, 32.5), and ST + PPR (8.9%, 95%CI = 7.7, 10.4). Recreational use was reported by 28.4% (95% CI = 26.5, 30.4) of the sample. The odds of extra-medical use of PPR-only (aRRR = 3.1, 95%CI = 2.1, 4.5) and ST + PPR (aRRR = 1.9, 95%CI = 1.2, 3.1) as opposed to ST-only, were greater among Non-Hispanic Blacks than Non-Hispanic Whites. Compared to non-alcohol users, those with a past-12 months diagnosis of alcohol use disorder were more likely to use ST + PPR rather than ST-only (aIRR = 2.0, 95%CI = 1.1, 3.7). Non-Hispanic Blacks (aOR = 0.6, 95%CI = 0.4, 08) and individuals living in rural areas (aOR = 0.5, 95%CI = 0.3, 09) were less likely to report extra-medical use of prescription medications for recreational reasons than Non-Hispanic Whites and those residing in large metropolitan areas, respectively. CONCLUSIONS: Extra-medical use of PPR-only and ST + PPR as an aid to sleep, is prevalent among Non-Hispanic Blacks, young adults, and those residing in rural areas. Most individuals reported that extra-medical use of prescription medications was primarily motivated by sleep reasons, rather than by sleep and recreational reasons. Potential interventions include access to sleep treatments, education on the effectiveness and risk associated with extra-medical use and co-use of prescription medications for sleep, and research on sleep-related disparities.


Subject(s)
Analgesics/therapeutic use , Hypnotics and Sedatives/therapeutic use , Prescription Drug Misuse/statistics & numerical data , Sleep Wake Disorders/drug therapy , Tranquilizing Agents/therapeutic use , Adolescent , Adult , Alcoholism/epidemiology , Analgesics, Opioid/therapeutic use , Drug Prescriptions/statistics & numerical data , Female , Humans , Logistic Models , Male , Middle Aged , Prevalence , Recreational Drug Use/statistics & numerical data , Sleep , Sleep Aids, Pharmaceutical/therapeutic use , Substance-Related Disorders/epidemiology , Surveys and Questionnaires , United States/epidemiology , Young Adult
12.
Sex Transm Infect ; 97(4): 282-289, 2021 06.
Article in English | MEDLINE | ID: mdl-33452129

ABSTRACT

INTRODUCTION: In the last decade diagnoses of most STIs have risen among men who have sex with men (MSM). Although a significant proportion of this is likely due to increased STI screening, understanding the role of behavioural drivers remains critical. We measure the associations between stimulant use to enhance and prolong sexual experiences (chemsex) and bacterial STI diagnoses in UK MSM, individually considering HIV-diagnosed MSM, pre-exposure prophylaxis (PrEP) users and other MSM. METHODS: We used the UK 2017-2018 European MSM Internet Survey data (n=9375). We constructed causal inference models using multivariable logistic regression, calculating adjusted OR (aOR) and 95% CI of the associations between participation in recent (≤12 months) exclusively dyadic or multipartner chemsex versus no chemsex and recent self-reported diagnoses of syphilis, gonorrhoea and chlamydia. RESULTS: Among MSM with an HIV diagnosis, 25% of users indicated recent multipartner chemsex, vs 28% of PrEP users and 5% of other MSM. Adjusting for age, ethnicity, UK birth, cis-trans status, sexual identity, education, settlement size and relationship status, participation in recent multipartner chemsex versus no chemsex was associated with greater odds of recent syphilis, gonorrhoea and chlamydia diagnosis. aORs for recent syphilis, gonorrhoea and chlamydia diagnoses were 2.6 (95% CI 1.7 to 4.1), 3.9 (95% CI 2.6 to 5.8) and 2.9 (95% CI 1.9 to 4.3), respectively, in HIV-diagnosed MSM; 1.9 (95% CI 1.1 to 3.3), 2.9 (95% CI 2.0 to 4.2) and 1.9 (95% CI 1.3 to 2.8), respectively, in PrEP users; and 4.0 (95% CI 2.3 to 6.9), 2.7 (95% CI 1.9 to 3.8) and 2.3 (95% CI 1.6 to 3.4), respectively, in other MSM. Conversely, exclusively dyadic chemsex had no significant associations with bacterial STI diagnoses among HIV-diagnosed MSM, only gonorrhoea (aOR 2.4, 95% CI 1.2 to 4.7) among PrEP users and syphilis (aOR 2.8, 95% CI 1.4 to 5.6) among other MSM. DISCUSSION: Multipartner chemsex may drive the association between chemsex and bacterial STI diagnoses and thus should be the focus of future tailored chemsex interventions. Additionally, PrEP acceptability among MSM and particularly chemsex participants has generated an emergent group suitable for such interventions.


Subject(s)
Chlamydia Infections/diagnosis , Gonorrhea/diagnosis , Homosexuality, Male/statistics & numerical data , Recreational Drug Use/statistics & numerical data , Sexual Behavior/statistics & numerical data , Sexual and Gender Minorities/statistics & numerical data , Syphilis/diagnosis , Adult , Chlamydia Infections/epidemiology , Gonorrhea/epidemiology , HIV Infections/diagnosis , HIV Infections/epidemiology , Humans , Male , Models, Theoretical , Pre-Exposure Prophylaxis/statistics & numerical data , Sexual Partners , Syphilis/epidemiology , United Kingdom/epidemiology
13.
Am J Perinatol ; 38(1): 65-75, 2021 01.
Article in English | MEDLINE | ID: mdl-31430821

ABSTRACT

OBJECTIVE: This study aimed to study the relationship between prenatal marijuana and infant birth weight using natural cohorts established before, during and after the 20-month lapse between legalization and legal recreational sales in Washington State. STUDY DESIGN: Over 5 years, 5,343 pregnant women with documented urine drug screen (UDS) results delivered at Tacoma General Hospital or Good Samaritan Hospital. Maternal medical data were extracted for three delivery cohorts established based on before (T1), during (T2), and after legalization (T3) of recreational marijuana and legalized availability. Univariate and multivariate models were created to study marijuana exposure on infants' birth weight. RESULTS: Marijuana exposure increased the risk of low birth weight (LBW; odds ratio [OR] = 1.42, 95% confidence interval [CI]: 1.01-2.01). This was more pronounced in full-term babies (OR = 1.72, 95% CI: 1.10-2.69), and was independently associated with a higher risk for small for gestational age (SGA; OR = 1.51, 95% CI: 1.49-1.53). The associations between marijuana exposure and SGA were maintained in cohort-specific models (OR = 1.53, 95% CI: 1.01-2.32 for T2, and OR = 1.43, 95% CI: 1.01-2.02 for T3, respectively). CONCLUSION: Marijuana exposure verified by UDS was associated with LBW and SGA. However, recreational marijuana legalization and availability did not have direct impact on newborns' risk of LBW or SGA.


Subject(s)
Birth Weight/drug effects , Cannabis/adverse effects , Fetus/drug effects , Infant, Low Birth Weight , Maternal Exposure/adverse effects , Recreational Drug Use/legislation & jurisprudence , Adult , Analysis of Variance , Body Mass Index , Female , Humans , Infant, Newborn , Infant, Small for Gestational Age , Male , Maternal Age , Odds Ratio , Pregnancy , Recreational Drug Use/statistics & numerical data , Washington
14.
J Microbiol Immunol Infect ; 54(5): 952-962, 2021 Oct.
Article in English | MEDLINE | ID: mdl-32847749

ABSTRACT

BACKGROUND: It is unclear about the impact of recreational drug use on the adherence, drug-drug interaction and the occurrence of sexual transmitted diseases (STDs) among people living with HIV. MATERIAL AND METHODS: A retrospective study was conducted between Dec 2016, and July 2018 to assess the clinical impact of recreational drug consumption in people living with HIV with antiretroviral therapy. We collected data of the demographics, recreational drug use, laboratory results and STDs diagnoses. Potential drug-drug interactions were checked with reference databases. The association between recreational drug use and STDs, HIV viral load suppression and drug interactions were evaluated. RESULTS: A total of 462 participants were enrolled, included 384 recreational drug users and 78 non-recreational drug users. Younger age (adjusted odds ratio [aOR], 0.94; 95% CI: 0.91-0.98; p = 0.001), longer HIV infection period (aOR, 1.11; 95% CI: 1.03-1.20; p = 0.009) and poor antiretroviral drug adherence (1-2 pills missing per month: aOR, 6.82; 95% CI: 3.50-13.27; p < 0.001; >2 pills missing per month: aOR, 3.50; 95% CI: 1.28-9.61; p = 0.015) were factors associated with recreational drug use. Methamphetamine and nitrites were two most common recreational drugs. Recreational drug use was significantly associated with STDs in one-year follow-up period (aOR, 2.43; 95% CI: 1.11-5.32; p = 0.027) but was not significantly associated with unsuppressed viral load, though a trend was observed (OR, 2.23; 95% CI: 0.92-5.37; p = 0.074). Potential interactions with recreational drugs included 33.1% antiretroviral drugs and 31.3% medications for comorbidities. CONCLUSION: Recreational drug was associated with STDs. A great proportion of the patients consuming recreational drugs had potential interactions with antiretroviral drugs and medications for comorbidities. The association of recreational drug use and unsuppressed viral load warrants further investigation.


Subject(s)
HIV Infections/epidemiology , Recreational Drug Use/statistics & numerical data , Adult , Anti-Retroviral Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Drug Interactions , Female , HIV Infections/drug therapy , Humans , Male , Medication Adherence/statistics & numerical data , Middle Aged , Retrospective Studies , Sexually Transmitted Diseases/epidemiology , Taiwan/epidemiology , Viral Load/drug effects
15.
Obstet Gynecol ; 137(1): 91-99, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33278297

ABSTRACT

OBJECTIVE: To evaluate the prevalence and characteristics of recreational cannabis use in women with pelvic pain, and to examine the influence of cannabis legalization on these parameters. METHODS: We conducted a retrospective analysis of a prospective registry of women with self-reported moderate-to-severe pelvic pain referred to a tertiary care clinic in Vancouver, Canada, 2013-2019. We excluded patients aged 18 years or younger and those with unknown data on cannabis use. Demographic, clinical, and validated questionnaire data were extracted for two main analyses: 1) comparison of current cannabis users with current nonusers, and 2) comparison of current cannabis users who entered the registry before cannabis legalization (October 17, 2018) with those who entered the registry on or after legalization. RESULTS: Overall, 14.9% (509/3,426) of patients were classified as current cannabis users. Compared with nonusers, cannabis users were younger (P<.001), had lower levels of education (P<.001) and lower household income (P<.001), were taking opioids (P<.001), antiinflammatories (P=.003), neuromodulators (P=.020), and herbal medications (P<.001) more frequently. They had worse questionnaire scores for depression, anxiety, pain catastrophizing, quality of life, and pelvic pain severity (P<.001 for all). After cannabis legalization, prevalence of current cannabis use increased from 13.3% (366/2,760) to 21.5% (143/666) (P<.001). Compared with prelegalization, postlegalization users were associated with higher levels of education (P<.001), worse anxiety (P=.036), and worse pain catastrophizing (P<.001) scores. They were taking fewer antiinflammatories (P<.001), neuroleptics (P=.027) and daily opioids or narcotics (P=.026), but more herbal medications (P=.010). CONCLUSION: Recreational cannabis use increased among patients with pelvic pain after legalization in Canada. Cannabis users had worse pain-related morbidities. Postlegalization, cannabis users were less likely to require daily opioids compared with cannabis users before legalization. The role, perceived benefits, and possible risks of cannabis for pelvic pain require further investigation. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02911090.


Subject(s)
Marijuana Use , Pelvic Pain/therapy , Recreational Drug Use/statistics & numerical data , Adult , Female , Humans , Recreational Drug Use/legislation & jurisprudence , Retrospective Studies , Young Adult
16.
Int J STD AIDS ; 32(1): 75-82, 2021 01.
Article in English | MEDLINE | ID: mdl-33236659

ABSTRACT

Recreational drug use is higher in people living with HIV (PLHIV) than in the general population in Europe. This use increases the risk for drug-drug interactions (DDIs) and adverse events. We assessed the prevalence and clinical consequences of substance abuse among PLHIV. BESIDE was a cross-sectional, multi-center study in 2016/18, evaluating comorbidities, polypharmacy and recreational/illicit drug use in PLHIV on antiretroviral therapy (ART) in Germany. Legal and illicit drug use was recorded using two anonymous patient questionnaires one year apart (Q1 and Q2). The BESIDE study population consisted of 453 PLHIV (22% female, median age 46 years). Recreational drug use was reported by the majority (Q1: ever used 73%, within previous 6 months 56%): nitrite inhalants ("poppers"), cannabis and PDE-5 inhibitors were common across all age groups; ecstasy, (meth-)amphetamine and gamma-hydroxybutyrate/gamma-butyrolactone were predominantly reported by younger PLHIV. Based on Q2, two-thirds of PLHIV (67%) had been informed about potential risks of drug abuse by their doctors, whereas one-third (33%) had talked to their doctors on their own initiative with only 7% considering drug use in combination with ART a problem. Strikingly, 44% and 42% had undergone medical treatment or had been hospitalized due to drug use. These data emphasize the high clinical relevance of recreational drug use in PLHIV and the need for treating physicians to pro-actively communicate the potential risks.


Subject(s)
HIV Infections/complications , Illicit Drugs/adverse effects , Recreational Drug Use/statistics & numerical data , Substance-Related Disorders/epidemiology , Adult , Antiretroviral Therapy, Highly Active , Cross-Sectional Studies , Drug Interactions , Female , Germany/epidemiology , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Male , Middle Aged , Prevalence , Substance-Related Disorders/complications
17.
Sex Health ; 17(6): 538-542, 2020 12.
Article in English | MEDLINE | ID: mdl-33326745

ABSTRACT

Recreational drug use (RDU) among gay and bisexual men (GBM) is associated with higher-risk sexual behaviours, however this has not been well defined among older GBM. We investigated the association between RDU and sexual behaviours among older GBM in Sydney, Australia. 617 GBM aged 35-79 years self-reported their RDU in the past 6 months and sexual behaviours. Age-stratified univariable associations between RDU and behaviour were examined. GBM aged 35-44 years were the most likely to report RDU, with rates decreasing with increasing age (Ptrend < 0.001). Associations between RDU and higher-risk sexual behaviours were most consistently found among GBM aged 35-54 years.


Subject(s)
Age Distribution , Recreational Drug Use/statistics & numerical data , Sexual Behavior/statistics & numerical data , Sexual and Gender Minorities , Adult , Aged , Australia/epidemiology , Cohort Studies , Cross-Sectional Studies , Health Risk Behaviors , Humans , Male , Middle Aged
18.
Sex Health ; 17(6): 493-502, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33284741

ABSTRACT

Background Sexualised drug use has attracted interest due to the role it could play in increasing exposure to the transmission of HIV and other sexually transmissible infections. It also carries risks inherent to substance use and may influence psychosocial factors. This study characterised sexualised drug use among Latin America MSM Internet Survey (LAMIS) respondents in Chile, in order to identify aspects associated with the phenomenon. METHODS: LAMIS data were used to analyse: drug use (in any context, in sexual context and sexualised drug use), epidemiological aspects and psychosocial aspects. In addition, the associations between the sexualised drug use and these aspects were estimated. RESULTS: The prevalence of sexualised drug use was 24% (n = 4945). The drugs most used in a sexual context (n = 3365) were cannabis, poppers and viagra. Cocaine, ecstasy/MDMA (3,4-Methylenedioxymethamphetamine) and ketamine use were reported in sexual encounters with multiple partners. Living with HIV (adjusted odds ratio (AOR) = 1.92), having had sex with three or more casual partners in the past year (AOR = 2.02) and having engaged in sex without a condom with three or more casual partners in this period (AOR = 1.61) were aspects associated with sexualised drug use. Less social integration (AOR = 0.76) and internalised homonegativity (AOR = 0.85) were aspects associated with a decrease of possibility of practising sexual drug use. CONCLUSION: Sexualised drug use is an emerging phenomenon in Chile, whose complexity needs to be studied in all its dimensions to have a complete understanding of its effect on people's health.


Subject(s)
Recreational Drug Use/statistics & numerical data , Sexual Behavior/statistics & numerical data , Sexual and Gender Minorities/psychology , Adult , Aged , Aged, 80 and over , Chile , Cross-Sectional Studies , Humans , Latin America , Male , Middle Aged , Sexual Partners , Sexually Transmitted Diseases/epidemiology , Young Adult
19.
Article in English | MEDLINE | ID: mdl-33255602

ABSTRACT

This paper analyses compulsive Internet use among Spanish adolescents as measured by the Compulsive Internet Use Scale (CIUS) of the ESTUDES 2016 survey (national survey on drug use in secondary schools), which was recently added to the statistical programme of the Spanish National Plan on Drugs. We examined two subsamples of Spanish adolescents (those who suffer from compulsive Internet use and those who do not) while taking into account gender and age. Our general hypothesis was that adolescents who suffer from compulsive Internet use have a greater prevalence of alcohol, tobacco, cannabis, sedative, and new substance consumption as well as a greater prevalence of modes of consumption such as getting drunk, drinking with friends in public places (botellón), and binge drinking. While our results confirm these assumptions, they also suggest that gender and age play an ambivalent role in these associations.


Subject(s)
Compulsive Behavior , Internet , Recreational Drug Use , Substance-Related Disorders , Tobacco Smoking , Adolescent , Alcohol Drinking , Compulsive Behavior/complications , Compulsive Behavior/epidemiology , Female , Humans , Internet/statistics & numerical data , Male , Prevalence , Recreational Drug Use/statistics & numerical data , Spain , Substance-Related Disorders/complications , Substance-Related Disorders/epidemiology , Tobacco Smoking/epidemiology
20.
J Clin Psychiatry ; 81(6)2020 11 03.
Article in English | MEDLINE | ID: mdl-33147656

ABSTRACT

OBJECTIVE: While prescription stimulant misuse (PSM) is common in adolescents and young adults (AYAs), PSM motives are poorly understood. This study examined a number of PSM motives across the AYA age spectrum using the 2015-2018 National Survey on Drug Use and Health. METHODS: In all, 86,918 AYAs (aged 14-25 years) were included. Individual PSM motives (eg, to study) and motive categories (ie, cognitive enhancement only, recreational only, weight loss only, and combined motives) were examined by age. Logistic regression models examined links between individual motives or motive categories and educational status, substance use, DSM-IV substance use disorders (SUD), and mental health correlates. RESULTS: Significant differences were found across AYAs in cognitive enhancement only (14 years = 40.4%; 24 and 25 years = 71.2%; P < .0001) and recreational only (14 years = 25.8%; 24 and 25 years = 9.8%; P < .0001) or combined PSM motives, (14 years = 32.3%; 24 and 25 years = 18.0%; P = .008); college students and graduates had particularly high rates of cognitive enhancement only (college = 78.2%; graduates = 74.7%; non-college = 63.5%). Recreational-only and combined motives were significantly elevated in AYAs with any past-year SUD, especially to get high (78%-136% higher in those with SUD; P ≤ .001). While any PSM was associated with higher odds of SUD and mental health outcomes, including suicidal ideation, odds were highest for recreational or combined motives. CONCLUSIONS: Cognitive enhancement with PSM occurs more often in young adults compared to adolescents, college students endorse more cognitive enhancement than those not in school, and the presence of any PSM in AYAs is linked to more substance use, suicidal ideation, and other psychopathology. PSM prevention in adolescents as well as screening and intervention among AYA is highly recommended.


Subject(s)
Central Nervous System Stimulants , Motivation , Nootropic Agents , Prescription Drug Misuse/statistics & numerical data , Recreational Drug Use/statistics & numerical data , Students/statistics & numerical data , Suicidal Ideation , Adult , Age Factors , Female , Health Surveys , Humans , Male , United States/epidemiology , Universities , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...